Moreover, this study elucidates the regulatory mechanisms of SLC7A11‐AS1 and SLC7A11, providing a theoretical foundation of the SLC7A11‐AS1/SLC7A11 pair as a biomarker and therapeutic target for HCC. The gene discussed is SLC7A11; the disease is hepatocellular carcinoma.